Reps summon NAFDAC, police, SSS over deaths linked to suspected herbal drugs

Reps summon NAFDAC, police, SSS over deaths linked to suspected herbal drugs

The House of Representatives has resolved to summon officials of the National Agency for Food and Drug Administration and Control (NAFDAC), the Nigeria Police Force and the State Security Service (SSS) to explain measures being taken to curb the circulation of fake and potentially dangerous drugs and drinks in Nigeria.

The decision followed a motion of urgent public importance moved by David Agada (APC, Benue State) during Wednesday’s plenary.

Agada raised concerns over the alleged sale and consumption of an unregistered herbal medicinal product in his constituency, which reportedly left four people dead and 11 others ill.

Moving the motion, the lawmaker urged the House to intervene to prevent additional casualties.

He told lawmakers that on 31 October, three men identified as Muhammad Adamu, Musa Kala, reportedly from Sokoto state, and Muhammad Sule, from Bauchi state, allegedly introduced and sold a herbal product to residents of the constituency.

He said the sellers claimed the product could treat typhoid fever, waist pain and other ailments.

Agada said several residents bought and consumed the product but developed severe symptoms within hours, forcing some of them to seek emergency medical attention at different hospitals.

He listed the four deceased persons as Awugo Oyije, who died on 2 November; James Onma, who died on 4 November after being referred for further treatment, Ode Ogah, who died on 5 November; and Agi Edugbeke, who died on 11 November.

The lawmaker further identified 11 other affected residents who were receiving medical attention. They include Otumala Ochele, Binta Sule, Onu Oboh, Adoga Onu, Upa James, Igbo Pius, Ochele Genesis, Otumala Amos, Uwa Baku, Ate Okpune and Roman Ehile.

Two of the affected persons, he said, had been referred to hospitals in Makurdi, the Benue State capital.

Mr Agada warned that “more residents could be at risk because some people who consumed the product might not have been identified or could be receiving treatment outside recognised health facilities.”

He also questioned the product’s composition, source, manufacturing conditions, registration status, dosage and potential adverse effects, noting that none of these had been independently established.

 

CATEGORIES
Share This

COMMENTS

Wordpress (0)
Disqus ( )